Erytech Pharma SA's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Erytech Pharma SA is scheduled to report earnings on May 9, 2023, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Jun 21
Income Statement	-
Total Revenue	€ 0.00	€ 0.00	€ 0.00	€ 0.00	€ 0.00
Gross Profit	-	-	-	-	-
EBIT	€ 3.10M	€ -4.42M	€ 14.66M	€ -11.68M	€ -15.52M
EBITDA	€ 3.10M	€ -4.42M	€ 14.66M	€ -11.68M	€ -15.52M
Net Income Common Stockholders	€ 5.94M	€ -5.14M	€ 10.89M	€ -11.91M	€ -16.01M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	€ 0.00	€ 0.00	€ 54.35M	€ 0.00	€ 46.84M
Total Assets	-	-	€ 65.99M	-	€ 83.81M
Total Debt	€ 0.00	€ 0.00	€ 4.01M	€ 0.00	€ 25.23M
Net Debt	€ 0.00	€ 0.00	€ -50.35M	€ 0.00	€ -21.61M
Total Liabilities	-	-	€ 43.55M	-	€ 47.45M
Stockholders Equity	€ 0.00	€ 0.00	€ 22.44M	€ 0.00	€ 36.36M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in EUR

Erytech Pharma SA Earnings and Revenue History

Income Statement >

Erytech Pharma SA Debt to Assets

Balance Sheet >

Erytech Pharma SA Cash Flow

Cash Flow >

Erytech Pharma SA Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing